Glycobiology, 2001, Vol. 11, No. 10 803-811
© 2001 Oxford University Press
Release of polymannose oligosaccharides from vesicular stomatitis virus G protein during endoplasmic reticulum–associated degradation
Departments of Medicine and Biological Chemistry, Harvard Medical School and the Joslin Diabetes Center, 1 Joslin Place, Boston, Massachusetts 02215, USA
To further explore the localization of the N-deglycosylation involved in the endoplasmic reticulum (ER)–associated quality control system we studied HepG2 cells infected with vesicular stomatitis virus (VSV) and its ts045 mutant, as in this system oligosaccharide release can be attributed solely to the VSV glycoprotein (G protein). We utilized the restricted intracellular migration of the mutant protein as well as dithiothreitol (DTT), low temperature, and a castanospermine (CST)-imposed glucosidase blockade to determine in which intracellular compartment deglycosylation takes place. Degradation of the VSV ts045 G protein was considerably greater at the nonpermissive than at the permissive temperature; this was reflected by a substantial increase in polymannose oligosaccharide release. Under both conditions these oligosaccharides were predominantly in the characteristic cytosolic form, which terminates in a single N-acetylglucosamine (OS-GlcNAc1); this was also the case in the presence of DTT, which retains the G protein completely in the ER. However when cells infected with the VSV mutant were examined at 15°C or exposed to CST, both of which represent conditions that impair ER-to-cytosol transport, the released oligosaccharides were almost exclusively (> 95%) in the vesicular OS-GlcNAc2 form; glucosidase blockade had a similar effect on the wild-type virus. Addition of puromycin to glucosidase-inhibited cells resulted in a pronounced reduction (> 90%) in oligosaccharide release, which reflected a comparable impairment in glycoprotein biosynthesis and indicated that the OS-GlcNAc2 components originated from protein degradation rather than hydrolysis of oligosaccharide lipids. Our findings are consistent with N-deglycosylation of the VSV G protein in the ER and the subsequent transport of the released oligosaccharides to the cytosol where OS-GlcNAc2 to OS-GlcNAc1 conversion by an endo-ß-N-acetylglucosaminidase takes place. Studies with the ts045 G protein at the nonpermissive temperature permitted us to determine that it can be processed by Golgi endomannosidase although remaining endo H sensitive, supporting the concept that it recycles between the ER and cis-Golgi compartments.
1 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Chantret and S. E H Moore Free oligosaccharide regulation during mammalian protein N-glycosylation Glycobiology, March 1, 2008; 18(3): 210 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Appenzeller-Herzog and H.-P. Hauri The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function J. Cell Sci., June 1, 2006; 119(11): 2173 - 2183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Breuza, R. Halbeisen, P. Jeno, S. Otte, C. Barlowe, W. Hong, and H.-P. Hauri Proteomics of Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC) Membranes from Brefeldin A-treated HepG2 Cells Identifies ERGIC-32, a New Cycling Protein That Interacts with Human Erv46 J. Biol. Chem., November 5, 2004; 279(45): 47242 - 47253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Duvet, F. Foulquier, A.-M. Mir, F. Chirat, and R. Cacan Discrimination between lumenal and cytosolic sites of deglycosylation in endoplasmic reticulum-associated degradation of glycoproteins by using benzyl mannose in CHO cell lines Glycobiology, September 1, 2004; 14(9): 841 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Trombetta The contribution of N-glycans and their processing in the endoplasmic reticulum to glycoprotein biosynthesis Glycobiology, September 1, 2003; 13(9): 77R - 91R. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Spiro Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds Glycobiology, April 1, 2002; 12(4): 43R - 56R. [Abstract] [Full Text] [PDF]
|
|